Mature T-cell Neoplasms and Stem Cell Transplant: the Never-ending Story

Overview

Journal Haematologica

Specialty Hematology

Date 2022 Mar 24

PMID 35320923

Authors

Emmanuel Bachy

Affiliations

Soon will be listed here.

References

Park S, Horwitz S, Foss F, Pinter-Brown L, Carson K, Rosen S . The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study. Cancer. 2019; 125(9):1507-1517. PMC: 8269282. DOI: 10.1002/cncr.31861. View

Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J . Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group. Eur J Haematol. 2007; 79(1):32-8. DOI: 10.1111/j.1600-0609.2007.00856.x. View

Garcia-Sancho A, Bellei M, Lopez-Parra M, Gritti G, Cortes M, Novelli S . Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study. Haematologica. 2022; 107(11):2675-2684. PMC: 9614542. DOI: 10.3324/haematol.2021.279426. View

Reimer P, Rudiger T, Geissinger E, Weissinger F, Nerl C, Schmitz N . Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol. 2008; 27(1):106-13. DOI: 10.1200/JCO.2008.17.4870. View

Cederleuf H, Jakobsen L, Ellin F, de Nully Brown P, Larsen T, Bogsted M . Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based study. Leuk Lymphoma. 2017; 58(12):2815-2823. DOI: 10.1080/10428194.2017.1300888. View

Simon A, Peoch M, Casassus P, Deconinck E, Colombat P, Desablens B . Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. Br J Haematol. 2010; 151(2):159-66. DOI: 10.1111/j.1365-2141.2010.08329.x. View

Mercadal S, Briones J, Xicoy B, Pedro C, Escoda L, Estany C . Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol. 2008; 19(5):958-63. DOI: 10.1093/annonc/mdn022. View

Bachy E, Camus V, Thieblemont C, Sibon D, Casasnovas R, Ysebaert L . Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA). J Clin Oncol. 2021; 40(3):242-251. DOI: 10.1200/JCO.21.01815. View

Ellin F, Landstrom J, Jerkeman M, Relander T . Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry. Blood. 2014; 124(10):1570-7. DOI: 10.1182/blood-2014-04-573089. View

10.

Wilhelm M, Smetak M, Reimer P, Geissinger E, Ruediger T, Metzner B . First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation. Blood Cancer J. 2016; 6(7):e452. PMC: 5030384. DOI: 10.1038/bcj.2016.63. View

11.

DAmore F, Relander T, Lauritzsen G, Jantunen E, Hagberg H, Anderson H . Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012; 30(25):3093-9. DOI: 10.1200/JCO.2011.40.2719. View

12.

Horwitz S, OConnor O, Pro B, Trumper L, Iyer S, Advani R . The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma. Ann Oncol. 2021; 33(3):288-298. PMC: 9447792. DOI: 10.1016/j.annonc.2021.12.002. View

13.

Fossard G, Broussais F, Coelho I, Bailly S, Nicolas-Virelizier E, Toussaint E . Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers. Ann Oncol. 2017; 29(3):715-723. DOI: 10.1093/annonc/mdx787. View

14.

Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P . Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia. 2006; 20(9):1533-8. DOI: 10.1038/sj.leu.2404306. View